These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 947407)

  • 1. Evidence that functional subunits of antihemophilic factor (Factor VIII) are linked by noncovalent bonds.
    Poon MC; Ratnoff OD
    Blood; 1976 Jul; 48(1):87-94. PubMed ID: 947407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic evidence that the properties of human antihemophilic factor (factor VIII) are attributes of a single molecular species.
    Ratnoff OD; Slover CC; Poon MC
    Blood; 1976 Apr; 47(4):657-67. PubMed ID: 1260127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin activation of factor VIII: the effect of inhibitors.
    Rick ME; Hoyer LW
    Br J Haematol; 1977 Aug; 36(4):585-97. PubMed ID: 889721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular structural studies of human factor VIII.
    McKee PA; Andersen JC; Switzer ME
    Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
    Weiss HJ; Hoyer IW
    Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heckathorn's disease: variable functional dificiency of antihemophilic factor (factor VIII).
    Ratnoff OD; Lewis JH
    Blood; 1975 Aug; 46(2):161-73. PubMed ID: 1139038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of VIII:C in plasma: the dependence on protease activity and calcium.
    Rock GA; Cruickshank WH; Tackaberry ES; Ganz PR; Palmer DS
    Thromb Res; 1983 Mar; 29(5):521-35. PubMed ID: 6407138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.
    Harris RB; Newman J; Johnson AJ
    Biochim Biophys Acta; 1981 May; 668(3):456-70. PubMed ID: 6786356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of factor VIII in the presence of proteolytic inhibitors.
    Sussman II; Weiss HJ
    Thromb Haemost; 1978 Oct; 40(2):316-25. PubMed ID: 310586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII.
    Vermylen J; Bottecchia D; Szpilman H
    Br J Haematol; 1976 Oct; 34(2):321-30. PubMed ID: 974043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation.
    Rick ME; Hoyer LW
    Blood; 1973 Nov; 42(5):737-47. PubMed ID: 4200955
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VIII recombination after dissociation by CaCl12.
    Cooper HA; Griggs TR; Wagner RH
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2326-9. PubMed ID: 4525167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.